medRxiv: "Impact and cost-effectiveness of the 6-month BPaL…" - Qoto Mastodon

medRxiv @medrxivpreprint@qoto.org

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis https://www.medrxiv.org/content/10.1101/2023.07.28.23293104

Aug 01, 2023, 04:42 · · medRxiv article feed · · ·

Sign in to participate in the conversation